MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Overview Fund Activity
Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

25 hedge funds and large institutions have $2.41M invested in Medicenna Therapeutics Corp. Common Shares in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SPC
Sigma Planning Corp
Michigan
$187K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$51K
3
Citadel Advisors
Citadel Advisors
Florida
$7.9K
4
Millennium Management
Millennium Management
New York
$7.14K
5
TSS
Two Sigma Securities
New York
$11.2K

Top Sellers

1
DCM
DAFNA Capital Management
California
$0
2
AC
Annandale Capital
Texas
$0
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$3.03K
4
Verition Fund Management
Verition Fund Management
Connecticut
$159K
5
NDSI
Newman Dignan & Sheerar Inc
Rhode Island
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
26
DAFNA Capital Management
California
– -$318K -660,000 Closed
AC
27
Annandale Capital
Texas
– -$19K -40,000 Closed
NDSI
28
Newman Dignan & Sheerar Inc
Rhode Island
– -$6.22K -12,915 Closed
National Bank of Canada
29
National Bank of Canada
Quebec, Canada
– -$272 -600 Closed
1
2